Evaluation_NN
of_IN
the_DT
respiratory_JJ
epithelium_NN
of_IN
normals_NNS
and_CC
individuals_NNS
with_IN
cystic_JJ
fibrosis_NN
for_IN
the_DT
presence_NN
of_IN
adenovirus_NN
E1a_NN
sequences_NNS
relevant_JJ
to_TO
the_DT
use_NN
of_IN
E1a_NN
-_:
adenovirus_NN
vectors_NNS
for_IN
gene_NN
therapy_NN
for_IN
the_DT
respiratory_JJ
manifestations_NNS
of_IN
cystic_JJ
fibrosis_NN
._.

Lung_NN
disease_NN
associated_VBN
with_IN
disorders_NNS
such_JJ
as_IN
cystic_JJ
fibrosis_NN
-LRB-_-LRB-
CF_NN
-RRB-_-RRB-
may_MD
be_VB
amenable_JJ
to_TO
somatic_JJ
gene_NN
therapy_NN
in_IN
which_WDT
there_EX
is_VBZ
delivery_NN
of_IN
the_DT
normal_JJ
gene_NN
directly_RB
to_TO
the_DT
respiratory_JJ
epithelium_NN
using_VBG
E1a_NN
-_:
adenovirus_NN
-LRB-_-LRB-
Ad_NN
-RRB-_-RRB-
type_NN
2_CD
-_:
or_CC
5-based_JJ
vectors_NNS
._.

For_IN
safety_NN
reasons_NNS
,_,
the_DT
Ad_NN
vectors_NNS
are_VBP
rendered_VBN
replication_NN
deficient_JJ
by_IN
deletion_NN
of_IN
the_DT
E1a_NN
region_NN
._.

Because_IN
there_EX
is_VBZ
the_DT
theoretical_JJ
possibility_NN
of_IN
an_DT
E1a_NN
-_:
replication-deficient_JJ
vector_NN
replicating_VBG
as_IN
a_DT
result_NN
of_IN
recombination_NN
or_CC
complementation_NN
with_IN
Ad_NN
2\/5_CD
E1a_NN
sequences_NNS
present_JJ
in_IN
the_DT
target_NN
cell_NN
,_,
this_DT
study_NN
is_VBZ
directed_VBN
toward_IN
evaluating_VBG
respiratory_JJ
epithelium_NN
of_IN
normals_NNS
and_CC
individuals_NNS
with_IN
CF_NN
for_IN
the_DT
presence_NN
of_IN
E1a_NN
sequences_NNS
._.

Using_VBG
Ad_NN
2\/5_CD
E1a-specific_JJ
primers_NNS
and_CC
the_DT
polymerase_NN
chain_NN
reaction_NN
to_TO
evaluate_VB
DNA_NN
recovered_VBN
from_IN
freshly_RB
isolated_VBN
nasal_NN
and_CC
bronchial_JJ
epithelium_NN
recovered_VBN
by_IN
brushing_NN
,_,
E1a_NN
sequences_NNS
were_VBD
detected_VBN
in_IN
respiratory_JJ
epithelium_NN
of_IN
19_CD
of_IN
91_CD
normals_NNS
-LRB-_-LRB-
21_CD
%_NN
-RRB-_-RRB-
._.

In_IN
the_DT
E1a-positive_JJ
samples_NNS
,_,
the_DT
average_NN
of_IN
E1a_NN
copy_NN
number_NN
was_VBD
55_CD
+_CC
\/_CD
-_:
18\/10_CD
3_CD
recovered_JJ
cells_NNS
._.

In_IN
CF_NN
individuals_NNS
,_,
7_CD
of_IN
52_CD
-LRB-_-LRB-
13_CD
%_NN
-RRB-_-RRB-
had_VBD
detectable_JJ
E1a_NN
sequences_NNS
in_IN
the_DT
respiratory_JJ
epithelium_NN
,_,
with_IN
E1a_NN
copy_NN
number_NN
in_IN
the_DT
positive_JJ
samples_NNS
of_IN
80_CD
+_CC
\/_CD
-_:
21\/10_CD
3_CD
recovered_VBN
cells_NNS
._.

These_DT
results_NNS
demonstrate_VBP
that_IN
there_EX
are_VBP
detectable_JJ
Ad_NN
2\/5_CD
E1a_NN
sequences_NNS
in_IN
the_DT
respiratory_JJ
epithelium_NN
of_IN
a_DT
small_JJ
percentage_NN
of_IN
normals_NNS
and_CC
individuals_NNS
with_IN
CF_NN
._.

Because_IN
of_IN
the_DT
theoretical_JJ
potential_NN
of_IN
such_JJ
sequences_NNS
supporting_VBG
replication_NN
of_IN
E1a_NN
-_:
Ad_NN
vectors_NNS
,_,
human_JJ
gene_NN
therapy_NN
protocols_NNS
for_IN
CF_NN
utilizing_VBG
such_JJ
vectors_NNS
should_MD
consider_VB
evaluating_VBG
study_NN
individuals_NNS
for_IN
the_DT
presence_NN
of_IN
Ad_NN
2\/5_CD
E1a_NN
sequences_NNS
in_IN
the_DT
respiratory_JJ
epithelium_NN
._.

